2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1),
5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperazinyl)benzofuran-2-carboxamide,
68843, EMD,
EMB 68843,
EMB-68843,
EMB68843,
EMD 68843,
HCl, Vilazodone,
Hydrochloride, Vilazodone,
Viibryd,
vilazodone,
Vilazodone HCl,
vilazodone hydrochloride,
Vilazodone hydrochloride,
163521-08-2,
Vilazodone HCl,
Viibryd,
UNII-U8HTX2GK8J,
Vilazodone (Hydrochloride),
EMD 68843,
U8HTX2GK8J,
Vilazodone hydrochloride [USAN],
CHEBI:70705,
SB659746A,
5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide hydrochloride,
5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide hydrochloride,
EMD 68 843,
SB 659746A,
SB-659746A,
AK161007,
EMD-68843,
Vilazodone hydrochloride (USAN),
5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide hydrochloride,
EMD-68-843,
SB-659746-A,
Vilazodonei,
vilazodone-hcl,
2-Benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1),
2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1),
5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide hydrochloride,
5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide hydrochloride,
Viibryd (TN),
AC1OCFA0,
vilazodone monohydrochloride,
C26H27N5O2.ClH,
SCHEMBL867358,
CHEMBL1615374,
KS-00000SKE,
RPZBRGFNBNQSOP-UHFFFAOYSA-N,
BCP11496,
EMD68843,
2794AH,
MFCD00940014,
s4259,
AKOS024464039,
AN-5344,
API0009252,
CCG-213313,
CS-0549,
EBD2199528,
RL02096,
RL02097,
SB659746-A,
AC-25885,
HY-14261,
LS-34922,
Vilazodone hydrochloride, >=98% (HPLC),
AB0000947,
AX8294006,
A3919,
ST24050347,
SW219887-1,
D09699,
521V128,
J-525160,
1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride,
1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)piperazine hydrochloride,
1-[4-(5-cyanoindol-3-yl)butyl]4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride,
5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2carboxamide hydrochloride,
5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxamide hydrochloride,
2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride,
4-(2-carbamoyl-1-benzofuran-5-yl)-1-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-ium chloride,
5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide monohydrochloride,
5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide;hydrochloride,
Vilazodone hydrochloride solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,
Vilazodone,
CID6918313,
CS-O-15479,
V0149,
163521-08-2 (HCl),
163521-12-8,
Vilazodone hydrochloride, 98%, a 5-HT1A receptor partial agonist - 250MG 250mg,